Section Arrow
NNVC.NYSE-M
- NanoViricides
Quotes are at least 15-min delayed:2026/11/04 20:55 EST
Regular Hours
Last
 1.38
-0.05 (-3.50%)
Day High 
1.465 
Prev. Close
1.43 
1-M High
1.53 
Volume 
89.45K 
Bid
1.42
Ask
1.49
Day Low
1.38 
Open
1.46 
1-M Low
1.24 
Market Cap 
36.52M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.41 
20-SMA 1.38 
50-SMA 1.32 
52-W High 2.03 
52-W Low 0.85 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.41/0.50
Enterprise Value
36.52M
Balance Sheet
Book Value Per Share
0.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris Inc.1.11+0.3961+55.48%0.2PE
KPTIKaryopharm Therapeutics Inc.0.0729-0.0154-17.44%-- 
GERNGeron Corp1.08+0.15+16.13%-- 
INOInovio Pharmaceuticals1.62-0.04-2.41%-- 
RXRXRecursion Pharmaceuticals3.88+0.2+5.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.